GobyMeds vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Visit MEDVi - $179/mo→or find your match

GobyMeds beats MEDVi overall, scoring 8.4/10 vs 7.7/10. GobyMeds is more affordable at $169/mo vs $179/mo. Choose GobyMeds for budget-conscious users who want a modern, well-reviewed comp. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side look at GobyMeds and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

GobyMeds

#3 of 52

8.4/10

Fast-growing compounded GLP-1 provider with strong Reddit reviews, competitive pricing, and a clean user experience that punches above its price point.

Visit GobyMeds

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	GobyMeds	MEDVi
Our Score	8.4/10	7.7/10
Starting Price	$169/mo	$179/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Budget-conscious users who want a modern, well-reviewed compounded GLP-1 program	Users who want a low entry price with oral and injectable compounded options
Ranking	#3	#20
Get started	Visit GobyMeds	Visit MEDVi

Pros & Cons Compared

GobyMeds

Pros

+$169/mo standard monthly rate, or $99/mo on the 3-month starter bundle, among the most affordable for a full-service compounded program
+Consistently positive Reddit reviews citing fast shipping, responsive support, and clean UX
+Modern patient portal with real-time order tracking and easy provider messaging
+Quick onboarding, most patients approved and shipped within 48 hours of enrollment

Cons

−Tirzepatide and brand-name options added 2026 but at much higher price points ($299/mo+), the semaglutide program is the value story
−Newer company with less track record than established players like Ro or Hims
−No insurance billing and no superbills for FSA/HSA reimbursement

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Our Verdict

GobyMeds edges out MEDVi with a score of 8.4/10 vs 7.7/10. If budget is your priority, GobyMeds starts at $169/mo compared to MEDVi's $179/mo. Choose GobyMeds if you want: budget-conscious users who want a modern, well-reviewed compounded glp-1 program. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither GobyMeds nor MEDVi feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review